Valerie L. Pierce

Sr. VP, GC and Corp. Sect., Viracta Therapeutics, Inc.

Companies

NGM Biopharmaceuticals (United States)SVP, GC & CCO Mar 10, 2021 to Apr 8, 2024¹
Viracta Therapeutics, Inc.General counsel Jul 2, 2008 to Jul 2, 2008²
Viracta Therapeutics, Inc.Sr. VP, GC and Corp. Sect. Apr 20, 2007 to Sep 14, 2007³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NGM Biopharmaceuticals (United States)0 shares⁴Apr 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 5, 2024U 26,458 shares of NGM Biopharmaceuticals (United States)⁴
Jan 16, 2024Shares withheld for tax 5,021 shares at $1.34 of NGM Biopharmaceuticals (United States)⁵
Mar 2, 2023Granted 49,000 shares of NGM Biopharmaceuticals (United States)⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNGM Biopharmaceuticals (United States), SVP, GC & CCO
2
SEC EDGARViracta Therapeutics, Inc., General counsel
3
SEC EDGARViracta Therapeutics, Inc., Sr. VP, GC and Corp. Sect.
4
SEC EDGARNGM Biopharmaceuticals (United States) shares after the filing of Apr 5, 2024
5
SEC EDGARForm 4 filed Jan 18, 2024
6
SEC EDGARForm 4 filed Mar 6, 2023